Gul, O. O. Et Al. 2010. Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients. METABOLISM-CLINICAL AND EXPERIMENTAL , vol.59, no.1 , 64-69.

Gul, O. O., Tuncel, E., YILMAZ, Y., ULUKAYA, E., Gul, C. B., Kiyici, S., ... YILMAZTEPE ORAL, A.(2010). Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients. METABOLISM-CLINICAL AND EXPERIMENTAL , vol.59, no.1, 64-69.

Gul, Ozen Et Al. "Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients," METABOLISM-CLINICAL AND EXPERIMENTAL , vol.59, no.1, 64-69, 2010

Gul, Ozen O. Et Al. "Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients." METABOLISM-CLINICAL AND EXPERIMENTAL , vol.59, no.1, pp.64-69, 2010

Gul, O. O. Et Al. (2010) . "Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients." METABOLISM-CLINICAL AND EXPERIMENTAL , vol.59, no.1, pp.64-69.

@article{article, author={Ozen Oz Gul Et Al. }, title={Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients}, journal={METABOLISM-CLINICAL AND EXPERIMENTAL}, year=2010, pages={64-69} }